Expansion and Activation of Natural Killer Cells for Cancer Immunotherapy
Open Access
- 1 April 2009
- journal article
- review article
- Published by Annals of Laboratory Medicine in Annals of Laboratory Medicine
- Vol. 29 (2) , 89-96
- https://doi.org/10.3343/kjlm.2009.29.2.89
Abstract
Duck Cho, M.D. and Dario Campana, M.D.. Korean J Lab Med 2009;29:89-96. https://doi.org/10.3343/kjlm.2009.29.2.89Keywords
Funding Information
- National Cancer Institute (CA113482, CA21765)
- Assisi Foundation
- Fondation de Gouverneurs de l’Espoir
- American Lebanese Syrian Associated Charities
This publication has 68 references indexed in Scilit:
- Expansion of Highly Cytotoxic Human Natural Killer Cells for Cancer Cell TherapyCancer Research, 2009
- Human natural killer cellsBlood, 2008
- Up on the tightrope: natural killer cell activation and inhibitionNature Immunology, 2008
- Natural killer cell–directed therapies: moving from unexpected results to successful strategiesNature Immunology, 2008
- Bortezomib and Depsipeptide Sensitize Tumors to Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand: A Novel Method to Potentiate Natural Killer Cell Tumor CytotoxicityCancer Research, 2006
- Mechanisms of immune evasion of human neuroblastomaCancer Letters, 2005
- Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cellsBlood, 2005
- In search of the ‘missing self’: MHC molecules and NK cell recognitionPublished by Elsevier ,2003
- A new method for in vitro expansion of cytotoxic human CD3−CD56+ natural killer cellsHuman Immunology, 2001
- Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic CancerNew England Journal of Medicine, 1985